13 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
the revenues we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our ability to recoup our investment
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
in that country. Adverse pricing limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates
DRS
ONCR
Oncorus, Inc.
28 Jan 21
Draft registration statement
12:00am
limitations may hinder our ability to recoup our investment in one or more product candidates, even if our product candidates obtain marketing approval
10-Q
jgftu2x
12 Nov 20
Quarterly report
8:01am
424B4
dgj12
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
36khxy lpujv
11 Sep 20
IPO registration
4:49pm
DRS/A
l96dn378
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
laufa
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
v14f67re9ptaxbbt
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
ok7t0 f7nrl
31 Oct 19
Draft registration statement
12:00am
- Prev
- 1
- Next